[1] 郝溥辰,张星虎. 糖皮质激素受体α对预测多发性硬化患者激素反应性的价值[J]. 中国神经免疫学和神经病学杂志, 2015,22(1):9-11.
[2] Kassi E, Semaniakou A, Sertedaki A, et al.Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients[J]. J Neurol Sci, 2016, 363: 165-169.
[3] Melief J, Koper JW, Endert E, et al.Glucocorticoid receptor haplotypes conferring increased sensitivity (BclI and N363S) are associated with faster progression of multiple sclerosis[J]. J Neuroimmunol, 2016, 299: 84-89.
[4] Moradi M, Gharesouran J, Ghafouri-Fard S, et al.Role of NR3C1 and GAS5 genes polymorphisms in multiple sclerosis[J]. Int J Neurosci, 2020, 130(4): 407-412.
[5] Fischer HJ, Finck TLK, Pellkofer HL, et al.Glucocorticoid Therapy of Multipe Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes[J]. Front Immunol, 2019, 10: 1200.
[6] 张兴鹤,卢宏. 糖皮质激素对多发性硬化患者血清MMP-9、TIMP-1水平的调控作用[J]. 中风与神经疾病杂志,2012,29(5):37-40.
[7] 王仲坤. 髓系来源的抑制性细胞在多发性硬化临床患者及实验性自身免疫性脑脊髓炎中的变化及机制[D]. 长春:吉林大学,2016.
[8] 姜振,王海波,李建峰,等. 糖皮质激素受体在小鼠单纯疱疹病毒性面瘫中的表达变化[J]. 山东大学学报(医学版), 2011,49(5):43-47.
[9] 古林涛,王海波,李建峰,等. 病毒性面瘫小鼠脾脏糖皮质激素受体表达的研究[J]. 山东大学学报(医学版),2012,50(3):44-49.
[10] 王娟,张桂芳,郭岩. 急性期应用糖皮质激素对急性面神经麻痹预后的影响[J]. 临床医学研究与实践,2017,2(21):23-24.
[11] 李越. SHARPIN在HSV-1感染性面瘫小鼠脑干中的动态表达及糖皮质激素对其的抑制作用[D]. 济南:山东大学,2015.
[12] Liu W, Fan Z, Han Y, et al.Activation of NF-κB signaling pathway in HSV-1-induced mouse facial palsy: Possible relation to therapeutic effect of glucocorticoids[J]. Neuroscience, 2015, 289: 251-261.
[13] 李强. 糖皮质激素通过下调P38 MAPK信号通路发挥抑制面神经核团凋亡作用的机制研究[D]. 兰州:兰州大学,2019.
[14] Chao X, Fan Z, Han Y, et al.Effects of local application of methylprednisolone delivered by the C/GP-hydrogel on the recovery of facial nerves[J]. Acta Otolaryngol, 2015, 135(11): 1178-1184.
[15] 丁建峰. NR3C1基因多态性与糖皮质激素治疗全身型重症肌无力患者疗效关系的研究[D]. 青岛:青岛大学,2019.
[16] Xie Y, Meng Y, Li HF, et al.GR gene polymorphism is associated with inter-subject variability in response to glucocorticoids in patients with myasthenia gravis[J]. Eur J Neurol, 2016, 23(8): 1372-1379.
[17] 黄莹,赵重波,朱雯华, 等. 重症肌无力患者外周血白细胞糖皮质激素受体α、βmRNA表达与激素疗效的关系[J]. 复旦学报(医学版),2012,39(1):31-35.
[18] 赵翀翀,王欢,蔡宏斌,等. 糖皮质激素对重症肌无力患者相关免疫机制影响研究[J]. 中风与神经疾病杂志,2012,29(10):45-47.
[19] 庄战强,许文华,吴元波,等. 糖皮质激素对重症肌无力患者外周血调节性T细胞中Foxp3及其胞内CTLA-4表达的影响[J]. 安徽医科大学学报,2015,50(9):95-98.
[20] 赵旭. 糖皮质激素治疗对重症肌无力患者Tfh细胞亚群的作用[J]. 当代医学, 2017,23(35):35-37.
[21] 陈晓莉,陈毓茜,王玉忠,等. miR-155在全身型重症肌无力中的作用及地塞米松对miR-155的影响[J]. 中南大学学报(医学版),2012,37(8):777-782.
[22] Nguyen ET, Solomon MB.Sex differences in regional expression of the glucocorticoid receptor gene in Alzheimers' disease[J].Alzheimers Dementia, 2018, 14(7): 720.
[23] Kootar S, Frandemiche ML, Dhib G, et al.Identification of an acute functional cross-talk between amyloid-βand glucocorticoid receptors at hippocampal excitatory synapsses[J]. Neurobiol Dis, 2018, 118: 117-128.
[24] Canet G, Pineau F, Zussy C, et al.Glucocorticoid receptors signaling impairment potentiates amyloid-β oligomers-induced pathology in an acute model of Alzheimer’s disease[J]. FASEB J, 2020, 34(1): 1150-1168.
[25] Pedrazzoli M, Losurdo M, Paolone G, et al.Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer’s disease[J]. Neurobiol Dis, 2019, 132: 104569.
[26] Vaz-Silva J, Gomes P, Jin Q, et al.Endolysosomal degradation of Tau and its role in glucocorticoid-driven hippocampal malfunction[J]. EMBO J, 2018, 37(20): e99084.
[27] Chen H, Marc Lombès, Menuet DL.Glucocorticoid receptor represses brain-derived neurotrophic factor expression in neuron-like cells[J]. Mol Brain, 2017, 10(1): 12.
[28] Sun L, Chen Y, Shen X, et al.Inhibition of NOX2-NLRP1 signaling pathway protects against chronic glucocorticoids exposure-induced hippocampal neuronal damage[J]. Int Immunopharmacol, 2019, 74: 105721.
[29] Horowitz MA, Cattaneo A, Cattane N, et al.Glucocorticoids prime the inflammatory response of human hippocampal cells through up-regulation of inflammatory pathways[J]. Brain Behav Immun, 2020, 87: 777-794.
[30] 韩笑. 糖皮质激素引起神经损伤的机制研究[D]. 上海:华东师范大学,2012.
[31] Lopatkiewicz AM, Gradek-Kwinta E,Czyzycki M,et al.Glucocorticoid resistance is associated with poor functional outcome after stroke[J]. Cell Mol Neurobiol, 2020, DOI:10.1007/s10571- 020-00818-1.
[32] 胡文平. 糖皮质激素对颈动脉斑块稳定性的影响及其机制研究[D]. 上海:第二军医大学,2017.
[33] Lee BH, Wen TC, Rogido M, et al.Glucocorticoid Receptor Expression in the Cortex of the Neonatal Rat Brain with and without Focal Cerebral Ischemia[J]. Neonatology, 2007, 91(1): 12-19.
[34] De la Tremblaye PB, Raymond J, Milot MR, et al. Evidence of lasting dysregulation of neuroendocrine and HPA axis function following global cerebral ischemia in male rats and the effect of Antalarmin on plasma corticosterone level[J]. Horm Behav, 2014, 65(3): 273-284.
[35] Sun WH, He F, Zhang NN, et al.Time dependent neuroprotection of dexamethasone in experimental focal cerebral ischemia: The involvement of NF-κB pathways[J]. Brain Research, 2018, 1701: 237-245.
[36] Jing Y, Hou Y, Song Y, et al.Methylprednisolone improves the survival of new neurons following transient cerebral ischemia in rats[J]. Acta Neurobiol Exp,2012,72(3):240-252.
[37] Srinivasan M, Lahiri N, Thyagarajan A, et al.Nuclear factor-kappa B: Glucocorticoid- induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease model[J]. Alzheimers Dement(NY), 2018, 4: 488-498.
[38] Yong L, Lei H, Qingyi M, et al.Repression of the Glucocorticoid Receptor Aggravates Acute Ischemic Brain Injuries in Adult Mice[J]. Int J Mol Sci, 2018, 19(8): 2428.
[39] Zub E, Canet G, Garbelli R, et al.The GR-ANXA1 pathway is a pathological player and a candidate target in epilepsy[J]. FASEB J, 2019, 33(12): 13998-14009.
[40] Ghosh C, Hossain M, Mishra S, et al.Modulation of glucocorticoid receptor in human epileptic endothelial cells impacts drug biotransformation in an in vitro blood-brain barrier model[J]. Epilepsia, 2018, 59(11): 2049-2060.
[41] 董军,张鹏,陈阳美. 新发难治性癫痫持续状态研究进展[J].癫痫杂志,2019,5(1):30-33.
[42] Bakker DP, Catsman-Berrevoets CE, Neuteboom RF.Effectiveness of a hybrid corticosteroid treatment regimen on refractory childhood seizures and a review of other corticosteroid treatments[J]. Eur J Paediatr Neurol, 2015, 19(5): 553-560.
[43] 王广燕. 糖皮质激素对杏仁核GABA能和谷氨酸能神经元功能的影响及其机制研究[D]. 青岛:青岛大学,2017.
[44] Lopes MW, Leal RB, Guarnieri R, et al.A single high dose of dexamethasone affects the phosphorylation state of glutamate AMPA receptors in the human limbic system[J]. Transl Psychiatry, 2016, 6(12): e986.
[45] Yang N, Li YC, Xiong TQ, et al.Dexamethasone ameliorates the damage of hippocampal filamentous actin cytoskeleton but is not sufficient to cease epileptogenesis in pilocarpine induced epileptic mice[J]. Epilepsy Res, 2019, 154: 26-33.
[46] Vizuete AFK, Hansen F, Negri E, et al.Effects of dexamethasone on the Li-pilocarpine model of epilepsy:protection against hippocampal inflammation and astrogliosis[J]. J Neuroinflammation, 2018, 15(1): 68. |
